treatment algorithms - Robuta Search

https://www.ihs.gov/diabetes/clinician-resources/dm-treatment-algorithms/ Diabetes Treatment Algorithms | Clinical Resources The Indian Health Service (IHS), an agency within the Department of Health and Human Services, is responsible for providing federal health services to American... diabetes treatment algorithms clinical resources https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2017.00038/full Frontiers | Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous... A number of developments have altered the treatment paradigm for metastatic non-small cell, non-squamous lung cancer. These include increasing knowledge of m... for patients with current treatment https://clarivate.com/life-sciences-healthcare/report/algocg0032-2025-biopharma-multiple-sclerosis-current-treatment-treatment-algorithms-claims-data-analysis-multiple/ Multiple Sclerosis - Current Treatment - Treatment Algorithms: Claims Data Analysis - Multiple... The treatment landscape for multiple sclerosis (MS) in the U.S. is rapidly evolving, with over 20 immunomodulatory disease-modifying therapies (DMTs) available... multiple sclerosis current treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algomd1515-biopharma-overactive-bladder-treatment-algorithms-claims-data-analysis-us-2015/ Overactive Bladder | Treatment Algorithms | Claims Data Analysis | US | 2015 | Clarivate Overactive bladder (OAB) is a common symptom complex characterized by urinary urgency, incontinence, frequency, and nocturia, which occur in the absence of... overactive bladder treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algocg0049-2026-biopharma-attention-deficit-hyperactivity-disorder-current-treatment-treatment-algorithms-claims-data/ Attention-Deficit-Hyperactivity Disorder - Current Treatment - Treatment Algorithms: Claims Data... Attention-deficit / hyperactivity disorder (ADHD), a common childhood neurodevelopmental condition that can persist into adulthood, affects about 6% of U.S.... attention deficit current treatment hyperactivity disorder algorithms https://clarivate.com/life-sciences-healthcare/report/algocg0050-2025-biopharma-insomnia-current-treatment-treatment-algorithms-claims-data-analysis-insomnia-us/ Insomnia - Current Treatment - Treatment Algorithms: Claims Data Analysis - Insomnia (US) |... Insomnia is a prevalent sleep disorder characterized by daytime dysfunction resulting from one or more sleep problems. The treatment of insomnia is highly... current treatment claims data insomnia algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoop0003-2026-biopharma-uveitis-current-treatment-treatment-algorithms-claims-data-analysis-noninfectious-uveitis/ Uveitis - Current Treatment - Treatment Algorithms: Claims Data Analysis - Noninfectious... Most vision loss from uveitis stems from persistent inflammation in the posterior segment of the eye. While noninfectious anterior uveitis is usually managed... current treatment claims data uveitis algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algone0002-2024-biopharma-diabetic-nephropathy-treatment-algorithms-claims-data-analysis-us-2024/ Diabetic Nephropathy | Treatment Algorithms: Claims Data Analysis | US | 2024 | Clarivate Diabetic nephropathy (DN), also referred to as diabetic kidney disease, is a common complication of diabetes. The DN drug market comprises a wide variety of... diabetic nephropathy treatment algorithms claims data analysis us https://clarivate.com/life-sciences-healthcare/report/algomd0027-2019-biopharma-obesity-overweight-treatment-algorithms-claims-data-analysis-us-2019/ Obesity/Overweight | Treatment Algorithms: Claims Data Analysis | US | 2019 | Clarivate Obesity is a significant public health concern in the United States. The body of evidence highlighting the physical and economic impact of obesity on society... treatment algorithms claims data obesity overweight analysis https://clarivate.com/life-sciences-healthcare/report/algocg0050-2021-biopharma-insomnia-treatment-algorithms-claims-data-analysis-us-2021/ Insomnia | Treatment Algorithms: Claims Data Analysis | US | 2021 | Clarivate Insomnia is a prevalent sleep disorder characterized by daytime dysfunction as a result of one or more sleep problems. The treatment of insomnia is highly... insomnia treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algocv0026-2026-biopharma-acute-coronary-syndrome-current-treatment-treatment-algorithms-claims-data-analysis-acute/ Acute Coronary Syndrome - Current Treatment - Treatment Algorithms: Claims Data Analysis - Acute... Acute coronary syndrome (ACS) is an umbrella term encompassing myocardial infarction and unstable angina. This report focuses on the secondary prevention of... acute coronary syndrome current treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoim0037-2019-biopharma-overactive-bladder-treatment-algorithms-claims-data-analysis-us-2019/ Overactive Bladder | Treatment Algorithms | Claims Data Analysis | US | 2019 | Clarivate Overactive bladder is a common condition that manifests as a complex set of symptoms in the lower urinary tract and affects both men and women. It is... overactive bladder treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algoim0046-2026-biopharma-atopic-dermatitis-atopic-eczema-current-treatment-treatment-algorithms-claims-data-analysis/ Atopic Dermatitis / Atopic Eczema - Current Treatment - Treatment Algorithms: Claims Data Analysis... Atopic dermatitis (AD) is a chronic, itchy, inflammatory skin disease often starting in childhood. It is usually treated with topical immunotherapy. Refractory... atopic dermatitis current treatment claims data eczema algorithms https://clarivate.com/life-sciences-healthcare/report/algoop0002-2019-biopharma-glaucoma-treatment-algorithms-claims-data-analysis-us-2019/ Glaucoma | Treatment Algorithms: Claims Data Analysis | US | 2019 | Clarivate Drug treatment of glaucoma focuses on reducing / controlling IOP and preserving visual function. Given the availability of therapies from several drug classes... glaucoma treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algoim0054-2019-biopharma-urticaria-treatment-algorithms-claims-data-analysis-chronic-inducible-urticaria-us-2019/ Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Inducible Urticaria | US | 2019 |... Market Outlook Chronic inducible urticaria (CIndU) includes different chronic urticaria subtypes that are inducible by specific triggers. Evidence exists that... treatment algorithms claims data urticaria analysis chronic https://clarivate.com/life-sciences-healthcare/report/algocv0011-2025-biopharma-heart-failure-current-treatment-treatment-algorithms-claims-data-analysis-heart-failure-with/ Heart Failure - Current Treatment - Treatment Algorithms: Claims Data Analysis - Heart Failure with... Drug treatment of heart failure with reduced ejection fraction (HFrEF) is well established, backed by a wealth of supporting evidence from clinical trials.... heart failure current treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoim0061-2019-biopharma-sarcoidosis-treatment-algorithms-claims-data-analysis-us-2019/ Sarcoidosis | Treatment Algorithms: Claims Data Analysis | US | 2019 | Clarivate MARKET OUTLOOK Sarcoidosis is an inflammatory disease of unclear etiology. It is characterized by tissue infiltration of granulomas, most commonly into the... treatment algorithms claims data sarcoidosis analysis us https://clarivate.com/life-sciences-healthcare/report/algomd0025-2021-biopharma-gout-treatment-algorithms-claims-data-analysis-us-2021/ Gout | Treatment Algorithms | Claims Data Analysis | US | 2021 | Clarivate MARKET OUTLOOK Gout is a chronic arthritic condition caused by elevated serum uric acid (sUA) characterized by intermittent acute flares. Treatment of the... gout treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algocg0029-2018-biopharma-epilepsy-treatment-algorithms-claims-data-analysis-us-2018/ Epilepsy | Treatment Algorithms | Claims Data Analysis | US | 2018 | Clarivate Market Outlook Epilepsy is a heterogeneous condition requiring individualized treatment. Neurologists consider many factors when selecting among the numerous... epilepsy treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algoim0065-2025-biopharma-chronic-urticaria-current-treatment-treatment-algorithms-claims-data-analysis-chronic/ Chronic Urticaria - Current Treatment - Treatment Algorithms: Claims Data Analysis - Chronic... The drug market for chronic spontaneous urticaria (CSU) is dominated by oral medications, including those are approved (e.g., first- and second-generation... chronic urticaria current treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoim0042-2024-biopharma-ulcerative-colitis-treatment-algorithms-claims-data-analysis-adult-us-2024/ Ulcerative Colitis | Treatment Algorithms: Claims Data Analysis | Adult | US | 2024 | Clarivate Ulcerative colitis (UC) is a chronic intermittent relapsing disorder of the large intestine and rectum. Treatment typically begins with conventional agents... ulcerative colitis treatment algorithms claims data https://clarivate.com/life-sciences-healthcare/report/algomd0044-2026-biopharma-hyperkalemia-current-treatment-treatment-algorithms-claims-data-analysis-hyperkalemia-us/ Hyperkalemia - Current Treatment - Treatment Algorithms: Claims Data Analysis - Hyperkalemia (US) |... Hyperkalemia is defined as a serum potassium level above 5.0 mEq/L. This report covers the management of chronic hyperkalemia through diuretic therapy,... current treatment claims data hyperkalemia algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algohe0001-2021-biopharma-immune-thrombocytopenic-purpura-treatment-algorithms-claims-data-analysis-us-2021/ Immune Thrombocytopenic Purpura | Treatment Algorithms: Claims Data Analysis | US | 2021 | Clarivate Immune thrombocytopenia purpura (ITP) is an autoimmune form of acquired thrombocytopenia that leads to a decrease in platelet production and an increased risk... treatment algorithms claims data immune purpura https://clarivate.com/life-sciences-healthcare/report/algocg0037-2025-biopharma-schizophrenia-treatment-algorithms-claims-data-analysis-us-2025/ Schizophrenia | Treatment Algorithms: Claims Data Analysis | US | 2025 | Clarivate Schizophrenia is a highly drug-treated condition that uses an array of medications, including atypical and typical antipsychotics, resulting in a complex... schizophrenia treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algomd0027-2020-biopharma-obesity-overweight-treatment-algorithms-claims-data-analysis-us-2020/ Obesity/Overweight | Treatment Algorithms: Claims Data Analysis | US | 2020 | Clarivate Obesity is a significant public health concern in the United States. The body of evidence highlighting the physical and economic impact of obesity on society... treatment algorithms claims data obesity overweight analysis https://clarivate.com/life-sciences-healthcare/report/algocv0010-2018-biopharma-peripheral-arterial-disease-treatment-algorithms-claims-data-analysis-us-2018/ Peripheral Arterial Disease | Treatment Algorithms | Claims Data Analysis | US | 2018 | Clarivate Treatment of peripheral arterial disease (PAD) has not changed significantly in recent years, and the typically prescribed drug classes for the prevention of... peripheral arterial disease treatment algorithms claims data https://clarivate.com/life-sciences-healthcare/report/algoim0056-2019-biopharma-irritable-bowel-syndrome-treatment-algorithms-claims-data-analysis-ibs-without-diarrhea/ Irritable Bowel Syndrome | Treatment Algorithms: Claims Data Analysis | IBS Without Diarrhea... Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency.... irritable bowel syndrome treatment algorithms claims data https://clarivate.com/life-sciences-healthcare/report/algocv0025-2026-biopharma-venous-thromboembolism-current-treatment-treatment-algorithms-claims-data-analysis-venous/ Venous Thromboembolism - Current Treatment - Treatment Algorithms: Claims Data Analysis - Venous... Venous thromboembolism (VTE) is the obstruction of a vein caused by a thrombus, described as deep vein thrombosis (DVT) or pulmonary embolism (PE), depending... venous thromboembolism current treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algomd0025-2018-biopharma-gout-treatment-algorithms-claims-data-analysis-us-2018/ Gout | Treatment Algorithms | Claims Data Analysis | US | 2018 | Clarivate Gout is a chronic condition characterized by intermittent acute flares caused by elevated serum uric acid (sUA). Treatment of the painful acute flares is... gout treatment claims data algorithms analysis us https://clarivate.com/life-sciences-healthcare/report/algous0915-biopharma-rheumatoid-arthritis-treatment-algorithms-claims-data-analysis-us-2015/ Rheumatoid Arthritis | Treatment Algorithms | Claims Data Analysis | US | 2015 | Clarivate For the estimated 2 million diagnosed patients in the United States who suffer from rheumatoid arthritis (RA), there are multiple prescription therapies that... rheumatoid arthritis treatment algorithms claims data analysis us https://clarivate.com/life-sciences-healthcare/report/algoim0046-2018-biopharma-atopic-dermatitis-atopic-eczema-treatment-algorithms-claims-data-analysis-pediatric-us-2018/ Atopic Dermatitis/Atopic Eczema | Treatment Algorithms: Claims Data Analysis | Pediatric | US |... Atopic dermatitis (AD) is a chronic, pediatric-onset, inflammatory skin disease marked principally by pruritus and eczema. Topical agents (e.g.,... atopic dermatitis eczema treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoim0051-2025-biopharma-hidradenitis-suppurativa-current-treatment-treatment-algorithms-claims-data-analysis/ Hidradenitis Suppurativa - Current Treatment - Treatment Algorithms: Claims Data Analysis -... Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory disorder affecting hair follicles. It is characterized by the occurrence of inflamed and... hidradenitis suppurativa current treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algomd0023-2017-biopharma-type-2-diabetes-treatment-algorithms-claims-data-analysis-us-2017/ Type 2 Diabetes | Treatment Algorithms: Claims Data Analysis | US | 2017 | Clarivate Historically, biguanides and sulfonylureas were the most heavily prescribed T2D drug classes. However, the DPP-IV inhibitors have recently overtaken... diabetes treatment claims data type algorithms https://clarivate.com/life-sciences-healthcare/report/algocg0031-2022-biopharma-migraine-prophylaxis-treatment-algorithms-claims-data-analysis-us-2021/ Migraine (Prophylaxis) | Treatment Algorithms | Claims Data Analysis | US | 2021 | Clarivate According to Clarivate epidemiology, more than 30 million people in the United States suffer from migraines. Despite being underused, migraine prophylaxis is a... migraine prophylaxis treatment algorithms claims data analysis us https://clarivate.com/life-sciences-healthcare/report/algocg0035-2024-biopharma-treatment-algorithms-claims-data-analysis-pediatric-attention-deficit-hyperactivity-disorder-us/ Treatment Algorithms: Claims Data Analysis - Pediatric Attention-Deficit/Hyperactivity Disorder... Attention-deficit/hyperactivity disorder (ADHD) is one of most common pediatric disorders and one that can continue into adulthood. For decades, pediatric ADHD... treatment algorithms claims data attention deficit analysis pediatric https://clarivate.com/life-sciences-healthcare/report/algocg0070-2025-biopharma-bipolar-disorder-current-treatment-treatment-algorithms-claims-data-analysis-bipolar/ Bipolar Disorder - Current Treatment - Treatment Algorithms: Claims Data Analysis - Bipolar... Among bipolar disorder (BPD) patients, depressive episodes are typically more common than manic or mixed episodes; symptoms of bipolar depression include... bipolar disorder current treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoim0076-2025-biopharma-vitiligo-current-treatment-treatment-algorithms-claims-data-analysis-vitiligo-us/ Vitiligo - Current Treatment - Treatment Algorithms: Claims Data Analysis - Vitiligo (US) |... Vitiligo is a chronic skin depigmentation disorder characterized by the destruction or loss of function of melanocytes. Its etiology and pathophysiology are... current treatment claims data vitiligo algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoim0042-2018-biopharma-ulcerative-colitis-treatment-algorithms-claims-data-analysis-adult-us-2018/ Ulcerative Colitis | Treatment Algorithms: Claims Data Analysis | Adult | US | 2018 | Clarivate The primary goal of ulcerative colitis (UC) treatment is to induce and maintain remission with few to no clinical symptoms remaining. Conventional therapies... ulcerative colitis treatment algorithms claims data https://clarivate.com/life-sciences-healthcare/report/algoim0059-2026-biopharma-asthma-current-treatment-treatment-algorithms-claims-data-analysis-adult-asthma-us/ Asthma - Current Treatment - Treatment Algorithms: Claims Data Analysis - Adult Asthma (US) |... Two types of pharmacotherapies are used in parallel to treat adult asthma: rescue drugs and maintenance therapies. Rescue drugs are inhaled therapies that... current treatment claims data asthma algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algocg0037-2026-biopharma-schizophrenia-current-treatment-treatment-algorithms-claims-data-analysis-schizophrenia-us/ Schizophrenia - Current Treatment - Treatment Algorithms: Claims Data Analysis - Schizophrenia (US)... Schizophrenia is a chronic psychiatric disorder that requires sustained pharmacologic management to reduce psychotic episodes and maintain long-term symptom... current treatment claims data schizophrenia algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algoim0046-2019-biopharma-atopic-dermatitis-atopic-eczema-treatment-algorithms-claims-data-analysis-pediatric-us-2019/ Atopic Dermatitis/Atopic Eczema | Treatment Algorithms: Claims Data Analysis | Pediatric | US |... Atopic dermatitis (AD) disproportionately affects children and adolescents, and its intermittent flares of itchy rash profoundly affect their quality of life.... atopic dermatitis eczema treatment claims data algorithms analysis https://clarivate.com/life-sciences-healthcare/report/algopn0001-2024-biopharma-osteoarthritic-pain-treatment-algorithms-claims-data-analysis-us-2024/ Osteoarthritic Pain | Treatment Algorithms | Claims Data Analysis | US | 2024 | Clarivate In the United States, osteoarthritic pain affects about 32 million people; an aging population and the increasing prevalence of obesity are predicted to fuel... pain treatment claims data algorithms analysis us https://blog.medicalalgorithms.com/ Info on Medical Treatment Algorithms Jan 7, 2026 - Visit Medal for the largest collection of free medical treatment algorithms with info on how medical algorithms will power clinical healthcare automation. medical treatment info algorithms https://www.news-medical.net/news/20230817/Can-machine-learning-algorithms-identify-patients-at-risk-of-a-delay-in-starting-cancer-treatment.aspx Can machine learning algorithms identify patients at risk of a delay in starting cancer treatment? Aug 17, 2023 - Multi-level machine learning models for estimating the risk of delay between cancer diagnosis and treatment initiation in a large group of cancer patients.